Company Analysis Hualan Biological Bacterin Inc.
1. Summary
Disadvantages
- Price (15.7 Β₯) is higher than fair price (12.18 Β₯)
- Dividends (0.91%) are below the sector average (1.83%).
- The stock's return over the last year (-48.78%) is lower than the sector average (-36.11%).
- The company's current efficiency (ROE=11.54%) is lower than the sector average (ROE=11.95%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Hualan Biological Bacterin Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -10.8% | -4.6% | -1.1% |
| 90 days | -14.2% | -16% | 19.1% |
| 1 year | -48.8% | -36.1% | 43.2% |
301207 vs Sector: Hualan Biological Bacterin Inc. has significantly underperformed the "Healthcare" sector by -12.67% over the past year.
301207 vs Market: Hualan Biological Bacterin Inc. has significantly underperformed the market by -91.98% over the past year.
Stable price: 301207 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 301207 with weekly volatility of -0.938% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (15.7 Β₯) is higher than the fair price (12.18 Β₯).
Price is higher than fair: The current price (15.7 Β₯) is 22.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (30.79) is lower than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (30.79) is lower than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.43) is lower than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (3.43) is lower than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.84) is higher than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (9.84) is higher than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (24.46) is higher than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (24.46) is lower than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -6.71% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-6.71%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (11.54%) is lower than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (11.54%) is higher than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (5.31%) is lower than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (5.31%) is higher than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.91% is below the average for the sector '1.83%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.91% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0.91% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (12.83%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
